We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $369M Turnover 0%
1-Year Est. Return 39.62%
This Fund
S&P 500
This Quarter Est. Return
-7.38%
1 Year Est. Return
+39.62%
3 Year Est. Return
+114.85%
5 Year Est. Return
+103.18%
10 Year Est. Return
+300.64%
AUM
$425M
AUM Growth
-$64M
Cap. Flow
-$33.7M
Cap. Flow %
-7.92%
Top 10 Hldgs %
72.34%
Holding
33
New
1
Increased
1
Reduced
8
Closed
–
Avg Time Held
5.3 years
Top 10 Avg Time Held
5 years
Top 20 Avg Time Held
5.9 years

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$4.13M
2
UHAL icon
U-Haul Holding
UHAL
+$51.7K

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$5.96M
2
ABBV icon
AbbVie
ABBV
+$3.06M
3
NEE icon
NextEra Energy
NEE
+$2.28M
4
GE icon
GE Aerospace
GE
+$1.56M
5
CMS icon
CMS Energy
CMS
+$1.38M

Sector Composition

Rank Sector Weight
1 Healthcare 33.34%
2 Utilities 31.69%
3 Industrials 9.75%
4 Financials 8.09%
5 Communication Services 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UHAL icon
1
U-Haul Holding
UHAL
$10.6B
$36.1M 8.49%
754,550
+1,000
+0.1% +$51.7K
2013 Q2
36 quarters
NEE icon
2
NextEra Energy
NEE
$179B
$35.6M 8.38%
460,000
-30,000
-6% -$2.28M
2013 Q2
36 quarters
ABBV icon
3
AbbVie
ABBV
$520B
$34.2M 8.05%
223,500
-20,000
-8% -$3.06M
2013 Q2
36 quarters
ALL icon
4
Allstate
ALL
$67.1B
$34.1M 8.03%
269,300
-10,000
-4% -$1.31M
2013 Q2
36 quarters
DUK icon
5
Duke Energy
DUK
$102B
$30.7M 7.22%
286,200
– –
2014 Q3
31 quarters
CMS icon
6
CMS Energy
CMS
$22.2B
$30.3M 7.12%
448,500
-20,000
-4% -$1.38M
2014 Q3
31 quarters
MRK icon
7
Merck
MRK
$357B
$29.5M 6.94%
323,700
– –
2013 Q2
36 quarters
XEL icon
8
Xcel Energy
XEL
$52.2B
$29.2M 6.87%
412,500
– –
2013 Q2
36 quarters
PFE icon
9
Pfizer
PFE
$164B
$28.5M 6.69%
542,700
– –
2013 Q2
36 quarters
T icon
10
AT&T
T
$151B
$19.3M 4.55%
922,000
-298,728
-24% -$5.96M
2022 Q1
1 quarter
AAPL icon
11
Apple
AAPL
$5.11T
$18.8M 4.42%
137,400
– –
2018 Q1
17 quarters
ABT icon
12
Abbott
ABT
$187B
$18.2M 4.28%
167,600
– –
2013 Q2
36 quarters
BHC icon
13
Bausch Health
BHC
$3.14B
$11.5M 2.71%
1,381,000
– –
2017 Q2
20 quarters
AVA icon
14
Avista
AVA
$3.44B
$8.92M 2.1%
205,000
– –
2014 Q3
31 quarters
SUPN icon
15
DELISTED
Supernus Pharmaceuticals
SUPN
$5.84M 1.37%
202,105
-20,000
-9% -$573K
2014 Q2
32 quarters
GE icon
16
GE Aerospace
GE
$336B
$5.37M 1.26%
135,430
-32,102
-19% -$1.56M
2019 Q1
13 quarters
SIRI icon
17
SiriusXM
SIRI
$10.7B
$4.64M 1.09%
75,784
– –
2014 Q4
30 quarters
NEM icon
18
Newmont
NEM
$115B
$3.88M 0.91%
65,000
– –
2019 Q2
12 quarters
FOCL icon
19
EDAP TMS
FOCL
$150M
$3.85M 0.9%
565,652
– –
2013 Q2
36 quarters
PRTK
20
DELISTED
Paratek Pharmaceuticals
PRTK
$3M 0.71%
1,557,312
– –
2019 Q2
12 quarters
WBD icon
21
DELISTED
Warner Bros
WBD
$2.99M 0.7%
+222,558
New +$4.13M
2022 Q2
0 quarters
ASH icon
22
Ashland
ASH
$3.45B
$2.58M 0.61%
25,000
– –
2013 Q2
36 quarters
AMYT
23
DELISTED
Amryt Pharma
AMYT
$2.2M 0.52%
315,182
– –
2021 Q3
3 quarters
FATE icon
24
Fate Therapeutics
FATE
$139M
$1.41M 0.33%
57,000
– –
2019 Q4
10 quarters
OGN icon
25
Organon & Co
OGN
$3.65B
$1.08M 0.25%
31,970
– –
2021 Q3
3 quarters

Similar funds

Bruce & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Bruce & Co held 33 positions worth $425M, down 13% from $489M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Bruce & Co withdrew a net $33.7M in Q2 2022, reducing 8 holdings. Its largest reduction was AT&T, cutting an estimated $5.96M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in Warner Bros worth $2.99M.

  • Bruce & Co's largest Q2 2022 buy was Warner Bros: 222,558 shares worth $2.99M.
  • Bruce & Co added most to U-Haul Holding in Q2 2022, an estimated $51.7K increase.
  • Bruce & Co's biggest Q2 2022 reduction was AT&T, cutting an estimated $5.96M.
  • Bruce & Co's ten largest holdings make up 72% of its $425M portfolio in Q2 2022.
  • Bruce & Co opened 1 new position and closed 0 in Q2 2022.
  • Bruce & Co's portfolio value fell 13% quarter-over-quarter to $425M.

Based on Bruce & Co's 13F filing for Q2 2022, filed 9 Aug 2022.